chrisvoncsefalvay/vaers-outcomes huggingface dataset:
About 26 hours after the vaccine experienced severe lower back where he had surgery 5 years ago. His daily back pain with activity is usually a 3 on a scale of 1-10. The pain after the vaccine was so severe he was unable to stand up or sit down without help and he rated his pain with activity as an 8. Today the pain is still an 8 with activity. He has not done any type of unusual activities that would cause the sudden increase in pain. The doctor's office has been closed due to the holiday and he is going to call the doctor's office today.
several days p/vax pt reported a rash on trunk, arms & hands;rash is sl pruritic;self tx w/DPH-some relief;rash persisted since immunization given 10OCT95;similar rxn recalled last yr not reported prior to vax
This spontaneous report as received from a  healthcare worker refers to a 38 year old female patient with no drug reactions or allergies. On 29-OCT-2013, the patient was vaccinated with a dose of PNEUMOVAX23 (lot # J004196, expiration date 06-DEC-2014), 0.5 ml, subcutaneously. On 29-OCT-2013, after she received PNEUMOVAX23 she experienced sharp pain, redness and  cellulitis at injection site, fever and chills. The patient was seen by the physician and treated with KEFLEX (500 mg, three times a day, for 10 days). The outcome of adverse events was unknown. Additional information has been requested.
Breakthrough case admission after two vaccines Pfizer 4/26/21 Lot# EW0150;  Pfizer 5/17/21 Lot# EW0150
Information has been received from a physician concerning a 9 week old female patient with a history of premature birth, born at 33 weeks and no known drug reactions or allergies who on 14-JUL-2011 was vaccinated orally with the first dose of ROTATEQ, 2 mL (lot#669962/1723Z) and expiration date 03-NOV-2012. There was no concomitant medication. The physician reported that on 14-JUL-2011 while administering ROTATEQ, her nurse observed the patient coughing and producing copious amounts of mucous. The nurse brought the patient to the physician where the doctor observed the patient in significant respiratory distress. The physician suctioned the mucous and continued to observe the child who exhibited more difficulty breathing and poor respiratory signs. An unspecified dose of epinephrine and albuterol were administered to the child. The patient was transported via emergency medical services (EMS) to a local hospital where a chest X-ray was performed (results not reported). The patient then was transferred to another hospital for further treatment. At the time of the report, the patient's outcome was unknown. The physician considered the patient's experiences to be immediately life-threatening and other important medical events. A lot check has been initiated. Additional information has been requested.
This spontaneous report as received from a physician's assistant refers to a patient of unknown age and gender. On 09-SEP-2015, the patient was vaccinated with an improperly stored dose of M-M-R II (lot # L003855 exp date 05-FEB-2017) (dose and route not reported). The temperature excursion was 53.8 F for 10.75 hours from 17-AUG-2015 to 06-NOV-2015. No adverse event was reported. This is one of several reports received from the same source. Additional information is not expected as all follow up information to complete the case was received.
Patient complained of dizziness and nausea following second covid moderna vaccination. We supplied water and chair and monitored him. While interviewing patient it was announced that he had consumed several beers during lunch 1-2 hours previously. He later told another front end associate following up with him that he actually had consumed whiskey. It is strongly believed that this played a large roll in his adverse reaction. It is believed that he experienced a mild syncopal reaction that was potentiated by the alcohol consumption.
Hot injection site; Itchy injection site; Red injection site; Swollen injection site; A spontaneous report was received from a Consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced red injection site, hot injection site, swollen injection site, itchy injection site.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 20 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot batch: Unknown) intramuscularly for prophylaxis of COVID-19 infection.  On 20 Jan 2021, the patient experienced red and swollen injection site.   On 30 Jan 2021, the patient experienced hot injection site and itchy injection site.  No treatment information was provided.  Laboratory investigation details were not provided.  Action taken with mRNA-1273 in response to the events was unknown.   On 20 Jan 2021 the outcome of red injection site and swollen injection site were resolved. On 30 Jan 2021 the outcome of hot injection site, itchy injection site were resolved. .
Fever lasted two days, severe headache lasted two days, body aches lasted over a week, nausea is still present, fatigue is still present,  arm soreness lasted a  little over a week, dizziness is still present. Stabbing pains in my hands, feet and legs started a few days after the vaccine and my rheumatologist ordered ultrasounds on my legs, which showed no presence of clots. The pains lasted for about 12 days. Pain in my chest and breasts occurred yesterday and lasted about 2 minutes.  Nipples are tender.
Pfizer-BioNTech COVID-19 Vaccine EUA: patient hospitalized with staph hominis bacteremia, body aches, fatigue, and chills. Received antimicrobials and supplemental oxygen. Discharged to home medically stable.
I had difficulty breathing so I went to the emergency room. Once I was checked at the emergency room, they found that oxygen level was below the 90% they administered oxygen and admitted me to the hospital. I had chest x-rays, complete blood panels ran, multiple tests were ran and I cannot remember them all. I had fluid built up around my heart and lungs, I also tested positive for COVID-19. I was given antibiotics, steroids, and LASIX to reduce the fluid buildup. I was released from the hospital after six days.
suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. In August 2019, less than 2 years after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient had reported for him/herself. The age at vaccination was not reported. The patient received Shingles vaccine in mid-2018. After receiving Shingles vaccine, the patient got shingles. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization and laboratory confirmation of shingles were not provided.
Breakthrough COVID-19 case with unknown symptom status. Hospitalized unknown date for unknown duration. Death 9/24/2021. From Vital Records = ACUTE CARDIOPULMONARY FAILURE, ACUTE RESPIRATORY FAILURE, COVID 19. Per vital records, ICD Codes include: Not yet coded ; Other Significant Conditions include: None listed.  place of death: HOSPITAL-INPATIENT, MEDICAL CENTER; certified by: PRONOUNCING AND CERTIFYING PHYSICIAN
SORE ARM, CHILLS, FEVER 102, DIZZINESS, FATIGUE, 72 HOURS WITH SEVER SYMPTOMS GONE IN 48 HOURS
erythema nodosum diagnosed on 12/16/21, present for 10-14 days
This spontaneous report was received from a healthcare worker refers to an unknown number of patients of unknown ages and gender. Since an unknown date in November 2012, the patients were vaccinated with a dose of improperly stored GARDASIL (lot #, expiration date and route not reported). No adverse event reported. This is one of the several reports from the same source. Additional information is not expected.
Information has been received from a registered pharmacist concerning a 67 year old male patient with no pertinent medical history and no drug reactions or allergies who on 13-SEP-2010 was vaccinated intramuscularly into the left arm with a 0.5 ml dose of PNEUMOVAX 23 (Lot # 667912/0933Z). Concomitant therapy included vaccination into the right arm with a dose of influenza virus vaccine (unspecified) (manufacturer unknown). The pharmacist reported that the patient developed 2-3 inch red area on his left arm at the injection site after receiving PNEUMOVAX 23. Patient came back to pharmacy to seek medical attention on an unspecified date. The outcome of the patient was not reported. No lab diagnostics studies were performed. Follow up information has been received from a registered pharmacist. It was reported that on 13-SEP-2010 the patient was vaccinated IM in the left deltoid with a dose of PNEUMOVAX 23 (Lot # 667912/0933Z) at 13:00. The registered pharmacist reported that on 15-SEP-2010 (reported as 15-SEP-2011) the patient experienced redness and swelling at the site of injection 2-3 inches wide. The patient recovered on 18-SEP-2010 (reported as 18-SEP-2011). The patient did not seek medical attention. No further information is expected.
Developed temp of 101.8, blood pressure of 146/99.  Nausea, major chills.  Late afternoon following injection. Took TYLENOL at 7:19p.m. On the 14th and again at 2:30 a.m. on the 15th.  Took ondansetron for nausea.
10:10 FLUZONE HIGH DOSE was given. Pt stated at 12:00 noon he started to have muscle ache, nausea and chills for the rest of the day. Next day (9/20/14) just headache. Sunday (9/21/14) pt felt fine.
severe shooting pains in my chest; severe shooting pains in my chest; This spontaneous case was reported by a pharmacist and describes the occurrence of PAIN (severe shooting pains in my chest) and CHEST PAIN (severe shooting pains in my chest) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (severe shooting pains in my chest) and CHEST PAIN (severe shooting pains in my chest). At the time of the report, PAIN (severe shooting pains in my chest) and CHEST PAIN (severe shooting pains in my chest) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact
0 range of motion in arm and shoulder shot was received in.  24 hours after had developed 99.8 fever, chills, body / joint ache, weak body , a little dizzy when moving around
Patient fall s/p COVID vaccine administration. Patient reported dizziness, no LOC, fell from standing striking head. Laceration to left upper forehead, sent to Urgent Care for sutures/closure.
started day 2 , heavy sweats all over lasting now 2 days , day and night , periods of  light headedness and spaced out feeling
had a rash 31 days after the first dose of the vaccine/she started breaking out in a rash; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation; cetirizine (CETIRIZINE), (Batch/Lot number: unknown); cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), (Batch/Lot number: unknown). The patient's relevant medical history included: "has reactions and sensitivities to a lot of medications" (unspecified if ongoing), notes: has reactions and sensitivities to a lot of medications; "has a lot of allergic reactions" (unspecified if ongoing), notes: has a lot of allergic reactions. The patient's concomitant medications were not reported. The following information was reported: RASH (non-serious), outcome "unknown", described as "had a rash 31 days after the first dose of the vaccine/she started breaking out in a rash". Relevant laboratory tests and procedures are available in the appropriate section.  Additional Information: The reporter stated that based on the recommendation of her allergist and her Primary Care Provider she took a Zyrtec, Cetirizine, 2 hours before the vaccine. She stated she is I&I positive and ANA positive, sensitive to a lot of medications. She was fine for the first 30 days. States that the doctors recommended her to get the vaccines 45-60 days apart instead of the recommended 21 days apart. 30-45 days after the vaccines she started breaking out in a rash. She did an antibody test and her level was 7.92. Reporter stated that the nurse at her allergist office told the caller that the staff there who had received three doses of the vaccine had results of 2500. The patient reported that, there was no information, so how did you know the vaccine was effective, specially someone who was autoimmune positive, no one wanted to put something in the body that will be harming instead of helping. Allergist and all their staff took a test after the first, second and booster dose of the vaccine, they had Pfizer and they were within the 25,000 range, so my 7.92 after just one vaccine seems low, the patient was trying to learn if in fact the vaccine may work for me, regardless of what vaccine it was.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
late for the second dose / first dose was administrated on October 29 2019; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 29th October 2019, batch number-5KK99 and expiration date-29th October 2021).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. No adverse events were reported The reporter did not consent to follow up.
facial and neck swelling 4 days after vaccine administration , seen Private physician who treated it with  Benadryl.
23 days after 1st Moderna shot, experienced a visual and/or ocular migraine that lasted approximately 15 minutes.  Squigly white lines were seen in vision and experienced extreme dizziness and had to sit down.  Field of vision was very limited during this time, with black spots and white lines, and could only see out of one eye.  Vision returned after about 20 minutes and was followed by a headache for approximately one hour.   No history of migraines of any type prior to this date.   Subsequent visual or ocular migraines did not occur.
Inflammatory response caused by vaccine set her into an arthritis flare; Arthritis bother when weather is inclimate/arthritis pain; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRITIS (Inflammatory response caused by vaccine set her into an arthritis flare) and ARTHRALGIA (Arthritis bother when weather is inclimate/arthritis pain) in an adult female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Rheumatoid arthritis.    No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced ARTHRITIS (Inflammatory response caused by vaccine set her into an arthritis flare) and ARTHRALGIA (Arthritis bother when weather is inclimate/arthritis pain). At the time of the report, ARTHRITIS (Inflammatory response caused by vaccine set her into an arthritis flare) was resolving and ARTHRALGIA (Arthritis bother when weather is inclimate/arthritis pain) had not resolved.        The action taken with mRNA-1273 (Spikevax) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medications were reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
2 days after patient's mother received the COVID vaccine the patient became fussy and eating less. Patient is breast fed.  Mom received Pfizer vaccine
patient received only the DTAP-IPV component of PENTACEL and that they did not reconstitute the HIB component so the patient did not get that part (with no reported adverse event); patient received only the DTAP-IPV component of PENTACEL and that they did not reconstitute the HIB component so the patient did not get that part (with no reported adverse event); Initial information received on 31-Aug-2023 regarding an unsolicited valid non-serious case received via other health professional.  This case involves a 2-month-old female patient received only the dtap-ipv component of diphtheria/tetanus/5 hybrid AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) vaccine [Pentacel (VERO)] and that they did not reconstitute the hib component so the patient did not get that part (with no reported adverse event).  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included hepatitis B vaccine for Prophylactic vaccination; pneumococcal vaccine CONJ 7V (CRM197) (Prevnar) for Prophylactic vaccination; and rotavirus vaccine for Prophylactic vaccination.  On 31-Aug-2023, the patient received a 0.5 ml total dose of suspect diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine Suspension for injection (strength: unknown) (lot: UJ851AA, expiry date: 01-Apr-2024) via intramuscular route in the right thigh for Immunization and patient received only the dtap-ipv component of pentacel and that they did not reconstitute the hib component so the patient did not get that part (with no reported adverse event) (product preparation issue and incorrect product formulation administered) (latency: same day).  Action taken with diphtheria, tetanus, AC pertussis, IPV and HIB vaccine (Pentacel (VERO)) was not applicable.  Outcome: Unknown.    This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
PT. FAINTED APROX 3 MINS AFTER RECEIVING COVID-19 VACCINE, SHE FELT DIZZY AND SAT IN CHAIR, FAINTED FOR ABOUT 3 SECONDS, EMTS CALLED EVAULUATED PT, LEFT UNDER OWN WILLPOWER WITH MOTHER AND SISTER
Severe sore throat ~24 hr. post IM flu vaccination.  Difficult swallowing and esophageal burning sensation with anything swallowed, including cool purified H2O.  Fatigue.  Lethargy.  No nausea, dizziness, vomiting or syncope.  Mild photophobia.  No fever or chills.  Single night sweat.  Vaccinated 6pm Pacific time Oct. 4, 2004.  Now, after 7 symptomatic days, throat shows only slightest improvement while pain seems to move down oesophagus and out eustachian tubes.
muscle and skin soreness at injection site radiating out approximately 2 inches lasting approximately 36 hours general fatigue starting on 1-1-221 lasting approximately 24 hours
I am fine as don't know if the legal statement about going to jail is helping the public with vacine hesitancy, or to build back trust with the CDC, WHO, FDA, pharmaceutical companies, or the NIH, or their VARES all birds of the same feather. I am fine and don't need your help. The vacine might have saved my life as I got Covid 19 really badly, even after getting the vaccine.  I don't need your help or the government's help and I don't need to go to your court or sue anybody. VARES, the FDA, NIH, WHO, pharmaceutical companies and CDC could make a lot of positive changes in the way they deal with people and the science and be more objective and neutral and maybe we wouldn't have so many citizens that have lost trust and respect and developed vacine hesitancy.  It is disheartening and disappointing.   My heart started to beat numerous times and pulpatate several times in less than a second. I had chest pain. My heart would beat irradictly.  I am better now. The vacine could have saved my life for all I know.   The circle of vaers, FDA and big pharma has caused distrust and vacine hesitancy in the population. I figured it is a waste of time to fill this out. I don't want anything from VARES, but figured you would want to know. Obviously, reading these statements throughout about imprisonment, none of these organizations want to know, unless it fits their narrative.   I am fine now and even though I got the vacine and had heart pulpatations that were very rapid and then a couple weeks later cought Covid 19 really badly even though being vaccinated, perhaps the vacine saved my life?  I am fine and need nothing from vaers and knew it was a waste of time to let you know the vacine messed up my heart for a couple weeks. My heart seems to be fine and I wish I never wasted my time with this report. My heart would beat numerous times in less than a second like muscle spasms....but in my heart. It has since went away, but I figured vaers might want to know, but it doesn't fit into the vaers, FDA, pharmaceutical company circle and I should have known that. Good luck to you vaers. If vaers, FDA and the pharma industry all took a more honest approach and moved away from the same narrative then you'd have a lot less vacine hesitancy. My father heard of my heart problem after getting the vaccine and he choose not to get it. He is on life support now. Vaers, FDA, CDC, who, all have a long way to go and should change their approach and conflicts of interest if they really want to get the population vaccinated and regain trust.
On the day following vaccination, the patient was standing at school (well fed and hydrated) when she turned white, eyes rolled back, and she fell to the floor with tonic, clonic movement of upper extremities bilaterally x 1 min. Sleepy following.
shortly after second injection of moderna vaccine, i began to have a rash.  it continued spreading and got to the point that i was bruising my skin scratching.  i went to my dermatologist 3 times.  they did  not do any testing...i mentioned that i had taken the vaccine around the time the rash began.  they gave me a prescription for a cream to put on three time a day.  i did...it did not work.  waent back dr. said scabies.  gave me prescription...did not work..went back.  dr said it was elastict. in panties threw away all panties and bought seamless panties didn't work. washed all linens...still rash.  it is now beginning to dry up after MONTHS of misery.  only using alcohol three times a day.  looks better  rash on stomach, buttocks,inside arms not top.  only on torso.  from shoulders to bottom of butt.  please excuse typos...computer not cooperating.